Talk Title:
“Design of a phase 2 first-in-ADPKD clinical trial of the Sodium/Glucose Cotransporter-2 inhibitor (SGLT2i) empagliflozin”
PKD RRC December 4, 2023 Scientific Roundtable Speaker: Dr. Stephen Seliger, University of Maryland School of Medicine
PKD RRC December 4, 2023 Scientific Roundtable Speaker: Dr. Stephen Seliger, University of Maryland School of Medicine
December 4 @ 4:00 pm - 5:00 pm EST
